Radicle HealthTM VIP: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on metabolic health and related health outcomes.
Adults, at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities
Assigned sex at birth will determine sex-specific recruitment and PROs (male vs female) employed, when needed
Resides in the United States
Has the opportunity for at least 30% improvement in their primary health outcome
None
Parallel
Placebo Metabolic Control 1
Dietary supplementParticipants will use their Placebo Metabolic Control 1 as directed for a period of 24 weeks
Active Metabolic Product 1
Dietary supplementParticipants will use their Active Metabolic Product 1 as directed for a period of 24 weeks
HbA1c Metabolic
A metabolic test assessed by an at-home (direct-to-consumer) biospecimen (dried blood from a finger-prick) assay.
Minimal clinically important difference in HbA1c metabolic
Odds of experiencing a (minimally) clinically important difference in metabolic testing assessed by evaluation of an at-home (direct-to-consumer) biospecimen (dried blood from a finger-prick) assay
Wellbeing assessed by RAND SF-36
Wellbeing assessed by RAND SF-36: Difference between rates of change over time in wellbeing score as assessed by RAND SF-36(scale 1-5; where the higher scores correspond to higher impact on wellbeing) and (scale 1-3; where the higher scores correspond to lower impact on wellbeing)
Blood glucose
Assessed by a Continuous Glucose Monitor (CGM)
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
